JT001 (VV116)

VV116 · Shanghai Vinnerna Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JT001 (VV116), covering 2022-09-21 to 2023-09-22. Get the full timeline:

Most recent: Clinical Trial Update: JT001 (VV116) for the Early Treatment of COVID-19 [Phase 2, Phase 3]